Winning In-Licensing Strategies in Developing Criteria for Compound Evaluations

Within the three strategy areas, specific topic areas include:

• Degree of strategy decision centralization
• Therapeutic or target area basis for focused approach
• Decision-making processes for filtering large numbers of compounds
• Connection between risk tolerance and stages in which deals are made
• Value of utility vs. clinical trial results

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.